Pub Date : 2025-01-13DOI: 10.1016/j.genhosppsych.2025.01.007
Gretchen J. Diefenbach , Sarah Collett , Sonata Black , M. David Rudd , Ralitza Gueorguieva , David F. Tolin
Objective
Diefenbach and colleagues (2024) found that inpatient Brief Cognitive-Behavioral Therapy for Suicide Prevention (BCBT-I) reduced the rate of six-month post-discharge psychiatric readmissions compared to treatment as usual (TAU). This treatment effect; however, was limited to inpatients, whom were not diagnosed with substance use disorder (SUD). The aim of this secondary analysis was to determine BCBT-I treatment effects and SUD moderation on post-discharge emergency department (ED) utilization.
Methods
Inpatients with a history of suicide attempt were assigned to BCBT-I + TAU (n = 94) or TAU alone (n = 106). Presence and number of ED visits were determined via self-report and electronic medical record review for six months after discharge. Generalized linear models for count and binary data were conducted.
Results
Adding BCBT-I to TAU reduced the odds and rate of post-discharge ED visits by three quarters [Odds Ratio estimate = 0.25, 95 % CI:(0.12, 0.46); Rate Ratio estimate = 0.24, 95 % CI:(0.11, 0.53)], but only among participants without SUD. Over one-third (36 %) of ED visits were related to suicide. Findings for suicide-related ED visits mirrored those of all-cause ED visits.
Conclusions
Adding BCBT-I to TAU reduced post-discharge ED utilization in participants without SUD. Additional research is needed to improve the efficacy of BCBT-I for patients with SUD.
{"title":"The effect of inpatient brief cognitive-behavioral therapy for suicide prevention on post-discharge emergency department utilization: Secondary analysis of a randomized clinical trial","authors":"Gretchen J. Diefenbach , Sarah Collett , Sonata Black , M. David Rudd , Ralitza Gueorguieva , David F. Tolin","doi":"10.1016/j.genhosppsych.2025.01.007","DOIUrl":"10.1016/j.genhosppsych.2025.01.007","url":null,"abstract":"<div><h3>Objective</h3><div>Diefenbach and colleagues (2024) found that inpatient Brief Cognitive-Behavioral Therapy for Suicide Prevention (BCBT-I) reduced the rate of six-month post-discharge psychiatric readmissions compared to treatment as usual (TAU). This treatment effect; however, was limited to inpatients, whom were not diagnosed with substance use disorder (SUD). The aim of this secondary analysis was to determine BCBT-I treatment effects and SUD moderation on post-discharge emergency department (ED) utilization.</div></div><div><h3>Methods</h3><div>Inpatients with a history of suicide attempt were assigned to BCBT-I + TAU (<em>n</em> = 94) or TAU alone (<em>n</em> = 106). Presence and number of ED visits were determined via self-report and electronic medical record review for six months after discharge. Generalized linear models for count and binary data were conducted.</div></div><div><h3>Results</h3><div>Adding BCBT-I to TAU reduced the odds and rate of post-discharge ED visits by three quarters [Odds Ratio estimate = 0.25, 95 % CI:(0.12, 0.46); Rate Ratio estimate = 0.24, 95 % CI:(0.11, 0.53)], but only among participants without SUD. Over one-third (36 %) of ED visits were related to suicide. Findings for suicide-related ED visits mirrored those of all-cause ED visits.</div></div><div><h3>Conclusions</h3><div>Adding BCBT-I to TAU reduced post-discharge ED utilization in participants without SUD. Additional research is needed to improve the efficacy of BCBT-I for patients with SUD.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"93 ","pages":"Pages 73-79"},"PeriodicalIF":4.1,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143003639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-11DOI: 10.1016/j.genhosppsych.2025.01.003
Sahil Munjal , Karina Irani , Crescentia Cho , Tiffany Ong
{"title":"Characterizing inpatients with self-inflicted gunshot wounds to the head and predictors of post-hospitalization disposition","authors":"Sahil Munjal , Karina Irani , Crescentia Cho , Tiffany Ong","doi":"10.1016/j.genhosppsych.2025.01.003","DOIUrl":"10.1016/j.genhosppsych.2025.01.003","url":null,"abstract":"","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"93 ","pages":"Pages 56-60"},"PeriodicalIF":4.1,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143003595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Although research has already shown the importance of promoting well-being during pregnancy and after birth, previous meta-analyses on the effectiveness of psychological interventions do not include wellbeing as a primary outcome measure, focusing instead on assessing the effectiveness in reducing symptoms. This study aimed at conducting a systematic review of the effects of psychological interventions on well-being during the perinatal period. A search was conducted in Psycinfo, PubMed, Web of Science (WOS) and Scopus for articles published from 2014 to 2024. A review of 16 randomized clinical trials revealed that most interventions were effective in both improving well-being and reducing clinical symptoms. Face-to-face, therapist-led, and group-based approaches showed better adherence. Positive changes in well-being were maintained over time, although the postpartum transition may have influenced the maintenance of results. This study highlights the importance of including well-being measures in clinical trials during the perinatal period and advocates for a shift toward promoting well-being alongside symptom management.
虽然研究已经表明了在怀孕期间和出生后促进健康的重要性，但之前关于心理干预有效性的荟萃分析并未将健康作为主要结果衡量标准，而是侧重于评估减轻症状的有效性。本研究旨在对围产期心理干预对健康的影响进行系统回顾。在Psycinfo， PubMed, Web of Science （WOS）和Scopus中检索了2014年至2024年发表的文章。对16项随机临床试验的回顾显示，大多数干预措施在改善幸福感和减少临床症状方面都是有效的。面对面、治疗师主导和以小组为基础的方法显示出更好的依从性。随着时间的推移，幸福感的积极变化得以保持，尽管产后过渡可能影响了结果的维持。本研究强调了在围产期的临床试验中包括健康措施的重要性，并倡导在症状管理的同时促进健康的转变。
{"title":"The efficacy of psychological interventions on well-being during the perinatal period: A systematic review","authors":"Elisa Nombela , Carlos Marchena , Almudena Duque , Covadonga Chaves","doi":"10.1016/j.genhosppsych.2025.01.006","DOIUrl":"10.1016/j.genhosppsych.2025.01.006","url":null,"abstract":"<div><div>Although research has already shown the importance of promoting well-being during pregnancy and after birth, previous meta-analyses on the effectiveness of psychological interventions do not include wellbeing as a primary outcome measure, focusing instead on assessing the effectiveness in reducing symptoms. This study aimed at conducting a systematic review of the effects of psychological interventions on well-being during the perinatal period. A search was conducted in Psycinfo, PubMed, Web of Science (WOS) and Scopus for articles published from 2014 to 2024. A review of 16 randomized clinical trials revealed that most interventions were effective in both improving well-being and reducing clinical symptoms. Face-to-face, therapist-led, and group-based approaches showed better adherence. Positive changes in well-being were maintained over time, although the postpartum transition may have influenced the maintenance of results. This study highlights the importance of including well-being measures in clinical trials during the perinatal period and advocates for a shift toward promoting well-being alongside symptom management.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"93 ","pages":"Pages 40-51"},"PeriodicalIF":4.1,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143003548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Telepsychiatry saw wide acceptance during the COVID-19 pandemic, when traditional healthcare facilities were inaccessible. Post-pandemic, however, user preferences for the service remain uncertain. This study explores user perceptions of telepsychiatry, particularly focusing on those who discontinued its use, to identify factors influencing service satisfaction and barriers to continued use.
Methodology
A mixed methods study was conducted on interviews with 165 patients who had utilised telepsychiatry services at a tertiary care teaching hospital in north India. Quantitative data were collected on telepsychiatry dropout rates, and bivariate analyses identified differences between continuing users and discontinuers. Qualitative data were gathered via semi-structured interviews, thematically analysed, and coded to examine personal, illness-related, and socio-environmental determinants of service choice.
Results
Analysis revealed a telepsychiatry dropout rate of 56.4 %, once physical OPDs became operational. Eight major themes - convenience, cost & time, therapeutic relationship, technological difficulty, service limitation, treatment outcome and privacy, affected telepsychiatry usage. Patients valued telepsychiatry for its convenience and time savings, while challenges such as brief consultations, frequent changes in doctors, and lack of privacy at home or work, prevented continued use. Technological barriers, especially for elderly and rural patients, and higher medication costs at local pharmacies were significant deterrents.
Conclusion
Telepsychiatry service use is dependent on a dynamic interplay between clinical condition, resource availability with user, service quality and available alternatives. Addressing these challenges remain crucial for integrating telepsychiatry into primary healthcare and ensuring its long-term sustainability.
{"title":"Telepsychiatry in post-pandemic India: A mixed methods exploration of patient perspectives and preferences toward telemedicine versus in-person consultations","authors":"Pooja Shakya , Koushik Sinha Deb , Ragul Ganesh , Arnab Datta , Rohit Verma , Rakesh Chadda","doi":"10.1016/j.genhosppsych.2025.01.005","DOIUrl":"10.1016/j.genhosppsych.2025.01.005","url":null,"abstract":"<div><h3>Background</h3><div>Telepsychiatry saw wide acceptance during the COVID-19 pandemic, when traditional healthcare facilities were inaccessible. Post-pandemic, however, user preferences for the service remain uncertain. This study explores user perceptions of telepsychiatry, particularly focusing on those who discontinued its use, to identify factors influencing service satisfaction and barriers to continued use.</div></div><div><h3>Methodology</h3><div>A mixed methods study was conducted on interviews with 165 patients who had utilised telepsychiatry services at a tertiary care teaching hospital in north India. Quantitative data were collected on telepsychiatry dropout rates, and bivariate analyses identified differences between continuing users and discontinuers. Qualitative data were gathered via semi-structured interviews, thematically analysed, and coded to examine personal, illness-related, and socio-environmental determinants of service choice.</div></div><div><h3>Results</h3><div>Analysis revealed a telepsychiatry dropout rate of 56.4 %, once physical OPDs became operational. Eight major themes - convenience, cost & time, therapeutic relationship, technological difficulty, service limitation, treatment outcome and privacy, affected telepsychiatry usage. Patients valued telepsychiatry for its convenience and time savings, while challenges such as brief consultations, frequent changes in doctors, and lack of privacy at home or work, prevented continued use. Technological barriers, especially for elderly and rural patients, and higher medication costs at local pharmacies were significant deterrents.</div></div><div><h3>Conclusion</h3><div>Telepsychiatry service use is dependent on a dynamic interplay between clinical condition, resource availability with user, service quality and available alternatives. Addressing these challenges remain crucial for integrating telepsychiatry into primary healthcare and ensuring its long-term sustainability.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"93 ","pages":"Pages 89-99"},"PeriodicalIF":4.1,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143079259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-09DOI: 10.1016/j.genhosppsych.2025.01.001
Kun Wang , Yan Li , Tingran Zhang , Hengxu Liu , Jiong Luo
Improving brain function impairment in people with substance use disorders (PSUD) is considered to be important in regulating their cyclic drug use impulse and relapse behavior. Physical exercise (PE) and repetitive transcranial magnetic stimulation (rTMS) may improve brain functional impairment in PSUD, respectively, but few studies have focused on the benefits and mechanisms of the combined use of the two. This editorial presents: 1) Both PE and rTMS alone appear to have positive effects on PSUD's reward system, cognitive function, and emotional regulation to varying degrees. 2) The mode of PE combined with rTMS seems to have a superimposed benefit on the brain function of PSUD by promoting the dynamic regulation of neurotransmitters and receptors, plasticity changes in neurogenesis and synapses, and the reversible development of brain structure and functional connections in PSUD. However, although this combination model provides a reference for subsequent targeted intervention therapy for drug use disorders, further studies are needed to provide more direct evidence of the corresponding benefits and mechanisms.
{"title":"Potential benefits and mechanisms of physical exercise and rTMS in improving brain function in people with drug use disorders","authors":"Kun Wang , Yan Li , Tingran Zhang , Hengxu Liu , Jiong Luo","doi":"10.1016/j.genhosppsych.2025.01.001","DOIUrl":"10.1016/j.genhosppsych.2025.01.001","url":null,"abstract":"<div><div>Improving brain function impairment in people with substance use disorders (PSUD) is considered to be important in regulating their cyclic drug use impulse and relapse behavior. Physical exercise (PE) and repetitive transcranial magnetic stimulation (rTMS) may improve brain functional impairment in PSUD, respectively, but few studies have focused on the benefits and mechanisms of the combined use of the two. This editorial presents: 1) Both PE and rTMS alone appear to have positive effects on PSUD's reward system, cognitive function, and emotional regulation to varying degrees. 2) The mode of PE combined with rTMS seems to have a superimposed benefit on the brain function of PSUD by promoting the dynamic regulation of neurotransmitters and receptors, plasticity changes in neurogenesis and synapses, and the reversible development of brain structure and functional connections in PSUD. However, although this combination model provides a reference for subsequent targeted intervention therapy for drug use disorders, further studies are needed to provide more direct evidence of the corresponding benefits and mechanisms.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"93 ","pages":"Pages 61-66"},"PeriodicalIF":4.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143003634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-09DOI: 10.1016/j.genhosppsych.2025.01.004
Hee-Ju Kang , Ju-Wan Kim , Sung-Wan Kim , Joon-Tae Kim , Man-Seok Park , Min-Chul Kim , Youngkeun Ahn , Myung Ho Jeong , Jae-Min Kim
Background
Life stressors are recognized as risk factors for the onset and prognosis of cardio-cerebrovascular events; however few studies have investigated the combined effect of life stressors and suicidal ideation (SI) on the long-term prognosis of patients with cardio- or cerebrovascular diseases.
Methods
A total of 1152 acute coronary syndrome (ACS) patients and 396 stroke patients were recruited from a tertiary university hospital in Korea at two weeks post-disease onset. Life stressors were assessed using the List of Threatening Events Questionnaire, and SI was evaluated using the “suicidal thoughts” item of the Montgomery–Åsberg Depression Rating Scale. Long-term outcomes were examined, with major adverse cardiac event (MACE) assessed over 5–12 years following ACS, and cerebro-cardiovascular events (CCVEs) assessed over 8–14 years following stroke. Cox regression models, adjusted for a range of covariates affecting life stressor, SI and long-term outcomes, were employed.
Results
In two independent cohorts, consistent associations were observed between life stressors and long-term outcomes. Life stressors were significantly associated with poor long-term composite outcomes, including MACE in ACS patients and CCVEs in stroke patients, particularly among those with SI at two weeks post-ACS or stroke. A significant interactive effect between life stressors and SI was observed only in ACS patients after adjustment for covariates.
Conclusions
Evaluating life stressors and SI during acute phase of cardio-cerebrovascular events can help identify high-risk patients for poor long-term cardio-cerebrovascular outcomes, enabling the implementation of intensive management strategies.
{"title":"Association of life stressors and suicidal ideation with long-term outcomes in patients with acute coronary syndrome and stroke","authors":"Hee-Ju Kang , Ju-Wan Kim , Sung-Wan Kim , Joon-Tae Kim , Man-Seok Park , Min-Chul Kim , Youngkeun Ahn , Myung Ho Jeong , Jae-Min Kim","doi":"10.1016/j.genhosppsych.2025.01.004","DOIUrl":"10.1016/j.genhosppsych.2025.01.004","url":null,"abstract":"<div><h3>Background</h3><div>Life stressors are recognized as risk factors for the onset and prognosis of cardio-cerebrovascular events; however few studies have investigated the combined effect of life stressors and suicidal ideation (SI) on the long-term prognosis of patients with cardio- or cerebrovascular diseases.</div></div><div><h3>Methods</h3><div>A total of 1152 acute coronary syndrome (ACS) patients and 396 stroke patients were recruited from a tertiary university hospital in Korea at two weeks post-disease onset. Life stressors were assessed using the List of Threatening Events Questionnaire, and SI was evaluated using the “suicidal thoughts” item of the Montgomery–Åsberg Depression Rating Scale. Long-term outcomes were examined, with major adverse cardiac event (MACE) assessed over 5–12 years following ACS, and cerebro-cardiovascular events (CCVEs) assessed over 8–14 years following stroke. Cox regression models, adjusted for a range of covariates affecting life stressor, SI and long-term outcomes, were employed.</div></div><div><h3>Results</h3><div>In two independent cohorts, consistent associations were observed between life stressors and long-term outcomes. Life stressors were significantly associated with poor long-term composite outcomes, including MACE in ACS patients and CCVEs in stroke patients, particularly among those with SI at two weeks post-ACS or stroke. A significant interactive effect between life stressors and SI was observed only in ACS patients after adjustment for covariates.</div></div><div><h3>Conclusions</h3><div>Evaluating life stressors and SI during acute phase of cardio-cerebrovascular events can help identify high-risk patients for poor long-term cardio-cerebrovascular outcomes, enabling the implementation of intensive management strategies.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"93 ","pages":"Pages 32-39"},"PeriodicalIF":4.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143003446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-09DOI: 10.1016/j.genhosppsych.2025.01.002
Guiting Su , Fang Liu , Xiaoqiu Yang , Ziqiong Chen , Yahong Kang , Shan Gao
Background and purpose
Cognitive function is the basis of human thinking and behavior. Cognitive impairment has a serious impact on each individual and imposes a financial burden to families and healthcare systems. Inhalation aromatherapy has advantages, due to its safety, convenience, lack of toxicity, and wide use in the treatment of cognitive impairment. This systematic review was conducted to provide evidence for the use of inhaled aromatherapy in patients with cognitive impairment.
Methods
We searched nine databases for pertinent Chinese and English studies published through November 2024 studies using inhaled aromatherapy in patients with cognitive impairment. Literature screening and data extraction were performed independently by two researchers and evaluated using the Cochrane Collaboration's quality criteria and were then cross-checked. A meta-analysis was carried out using Cochrane's Review Manager (RevMan, version 5.4), and we followed the PRISMA guidelines.
Results
We included fourteen studies involving 888 patients with cognitive impairment in our study. Meta-analyses indicated that inhaled aromatherapy increased Mini-mental State Examination (MMSE, mean difference MD = 3.89 95 % CI [3.19, 4.58], P < 0.00001) and Montreal Cognitive Assessment Scale (MoCA, MD = 4.11, 95 % CI [3.54, 4.68], P < 0.00001) scores and decreased Homocysteine levels (Hcy, MD = −2.27 95 % CI [−2.80, −1.74], P < 0.00001) in patients with cognitive impairment compared with controls.
Conclusion
Inhaled aromatherapy could improve global cognition and lower Hcy in patients with cognitive impairment.
{"title":"The effect of inhaled aromatherapy on cognitive function in patients with cognitive impairment: A systematic review and meta-analysis","authors":"Guiting Su , Fang Liu , Xiaoqiu Yang , Ziqiong Chen , Yahong Kang , Shan Gao","doi":"10.1016/j.genhosppsych.2025.01.002","DOIUrl":"10.1016/j.genhosppsych.2025.01.002","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Cognitive function is the basis of human thinking and behavior. Cognitive impairment has a serious impact on each individual and imposes a financial burden to families and healthcare systems. Inhalation aromatherapy has advantages, due to its safety, convenience, lack of toxicity, and wide use in the treatment of cognitive impairment. This systematic review was conducted to provide evidence for the use of inhaled aromatherapy in patients with cognitive impairment.</div></div><div><h3>Methods</h3><div>We searched nine databases for pertinent Chinese and English studies published through November 2024 studies using inhaled aromatherapy in patients with cognitive impairment. Literature screening and data extraction were performed independently by two researchers and evaluated using the Cochrane Collaboration's quality criteria and were then cross-checked. A meta-analysis was carried out using Cochrane's Review Manager (RevMan, version 5.4), and we followed the PRISMA guidelines.</div></div><div><h3>Results</h3><div>We included fourteen studies involving 888 patients with cognitive impairment in our study. Meta-analyses indicated that inhaled aromatherapy increased Mini-mental State Examination (MMSE, mean difference MD = 3.89 95 % CI [3.19, 4.58], <em>P</em> < 0.00001) and Montreal Cognitive Assessment Scale (MoCA, MD = 4.11, 95 % CI [3.54, 4.68], <em>P</em> < 0.00001) scores and decreased Homocysteine levels (Hcy, MD = −2.27 95 % CI [−2.80, −1.74], <em>P</em> < 0.00001) in patients with cognitive impairment compared with controls.</div></div><div><h3>Conclusion</h3><div>Inhaled aromatherapy could improve global cognition and lower Hcy in patients with cognitive impairment.</div></div>","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"93 ","pages":"Pages 20-31"},"PeriodicalIF":4.1,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142970483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01DOI: 10.1016/j.genhosppsych.2024.10.003
Maria J. Portella , Gara Arteaga-Henríquez , Javier de Diego-Adeliño , Joan Trujols , Dolors Puigdemont , Josefina Pérez , Carlo Alemany , Júlia Carrasco-Hernández , Marc Udina , Narcís Cardoner , Muriel Vicent-Gil
{"title":"Linking cognitive function and biological markers in depression: Can IL-6 plasma levels and attention domain be used as an ensemble classification system?","authors":"Maria J. Portella , Gara Arteaga-Henríquez , Javier de Diego-Adeliño , Joan Trujols , Dolors Puigdemont , Josefina Pérez , Carlo Alemany , Júlia Carrasco-Hernández , Marc Udina , Narcís Cardoner , Muriel Vicent-Gil","doi":"10.1016/j.genhosppsych.2024.10.003","DOIUrl":"10.1016/j.genhosppsych.2024.10.003","url":null,"abstract":"","PeriodicalId":12517,"journal":{"name":"General hospital psychiatry","volume":"92 ","pages":"Pages 113-114"},"PeriodicalIF":4.1,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142462471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号